Renal Outcomes With Tenofovir Alafenamide in Liver Transplant Recipients.

Liu, Joanne K; Vutien, Philip; Huang, Daniel Q; Ishigami, Masatoshi; Landis, Charles S; Nguyen, Mindie H

Liu, Joanne K; Vutien, Philip; Huang, Daniel Q; Ishigami, Masatoshi; Landis, Charles S; Nguyen, Mindie H.

Afiliación

Liu JK; University of Washington, Seattle, Washington.
Vutien P; Division of Gastroenterology and Hepatology, University of Washington, Seattle, Washington.
Huang DQ; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Ishigami M; Division of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Landis CS; Division of Gastroenterology and Hepatology, University of Washington, Seattle, Washington.
Nguyen MH; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California. Electronic address: mindiehn@stanford.edu.

Clin Gastroenterol Hepatol ; 21(2): 538-540.e4, 2023 02.

Article en En | MEDLINE | ID: mdl-35123081

Asunto(s)

Hepatitis B Crónica; Trasplante de Hígado; Humanos; Alanina/uso terapéutico; Tenofovir/efectos adversos; Adenina/efectos adversos; Hepatitis B Crónica/tratamiento farmacológico; Riñón/fisiología; Antivirales/efectos adversos; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Hígado / Hepatitis B Crónica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google